Sean McCutcheon
Stock Analyst at Raymond James
(n/a)
# 4,749
Out of 4,810 analysts
5
Total ratings
n/a
Success rate
-44.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENGN enGene Holdings | Initiates: Outperform | $23 | $4.00 | +475.00% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $9.54 | +319.29% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $38.56 | +81.54% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $33.74 | +154.89% | 1 | Mar 13, 2024 |
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $4.00
Upside: +475.00%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $9.54
Upside: +319.29%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $38.56
Upside: +81.54%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $33.74
Upside: +154.89%